Demo·seeded data·not investment advice
BioSight
/ insider trades · 30 tickers tracked
Txns 90d160
Next 7d1
Next 30d7
SLIPKODJUN–JUN 2026 → AUG–AUG 2026NEXTSRPTAdCom27 daysHOTImmunology2 upcoming
live tape
REGNsell−$2.2M·Apr 25INCYsell−$1.5M·Apr 25BPMCoption ex.$351.1K·Apr 25NTLAsell−$224.5K·Apr 25AKRObuy+$261.3K·Apr 25CRBUsell−$151.3K·Apr 25MRNAsell−$370.5K·Apr 24BPMCbuy+$2.7M·Apr 24BEAMaward$505.8K·Apr 24AKROsell−$848.2K·Apr 24RCKTsell−$374.1K·Apr 24BCRXsell−$1.0M·Apr 24VKTXbuy+$1.7M·Apr 23VKTXbuy+$817.3K·Apr 23MRNAsell−$3.0M·Apr 23RYTMsell−$483.5K·Apr 23ALNYsell−$485.7K·Apr 23BMYsell−$26.9M·Apr 23BCRXoption ex.$101.8K·Apr 23ALNYbuy+$539.3K·Apr 22KODbuy+$146.6K·Apr 22MDGLbuy+$1.1M·Apr 22VERVsell−$7.9M·Apr 22ARDXsell−$48.6K·Apr 22REGNsell−$2.2M·Apr 25INCYsell−$1.5M·Apr 25BPMCoption ex.$351.1K·Apr 25NTLAsell−$224.5K·Apr 25AKRObuy+$261.3K·Apr 25CRBUsell−$151.3K·Apr 25MRNAsell−$370.5K·Apr 24BPMCbuy+$2.7M·Apr 24BEAMaward$505.8K·Apr 24AKROsell−$848.2K·Apr 24RCKTsell−$374.1K·Apr 24BCRXsell−$1.0M·Apr 24VKTXbuy+$1.7M·Apr 23VKTXbuy+$817.3K·Apr 23MRNAsell−$3.0M·Apr 23RYTMsell−$483.5K·Apr 23ALNYsell−$485.7K·Apr 23BMYsell−$26.9M·Apr 23BCRXoption ex.$101.8K·Apr 23ALNYbuy+$539.3K·Apr 22KODbuy+$146.6K·Apr 22MDGLbuy+$1.1M·Apr 22VERVsell−$7.9M·Apr 22ARDXsell−$48.6K·Apr 22
§  inside track · form 4
live

What insiders are buying, selling, and when. Tap any name for the full dossier.

§  flow · 30d
Buys
$13.7M
Sells
$234.0M
Net flow
−$220.3M
Near catalyst
28
within 60d
net buyers
§  filters85 txns
Window
Action
Role
Min value
Catalyst proximity
§  the tape85 filings · sorted newest first
TickerInsider · roleActionSharesPriceValueDate · catalyst
REGN
Sell
16,897$128.71−$2.2M
Apr 25
INCY
Sell
21,225$70.21−$1.5M
Apr 25
BPMC
Option ex.
7,641$45.95$351.1K
Apr 25
NTLA
Sell
12,814$17.52−$224.5K
Apr 25
AKRO
Buy
11,938$21.89+$261.3K
Apr 25
11d to catalyst
CRBU
Sell
10,033$15.08−$151.3K
Apr 25
9d to catalyst
MRNA
Sell
5,233$70.79−$370.5K
Apr 24
BPMC
Buy
68,317$39.39+$2.7M
Apr 24
35d to catalyst
BEAM
Award
20,671$24.47$505.8K
Apr 24
AKRO
Sell
31,322$27.08−$848.2K
Apr 24
12d to catalyst
RCKT
Sell
23,715$15.77−$374.1K
Apr 24
BCRX
Sell
41,904$23.89−$1.0M
Apr 24
38d to catalyst
VKTX
Buy
52,629$31.54+$1.7M
Apr 23
37d to catalyst
VKTX
Buy
21,358$38.27+$817.3K
Apr 23
37d to catalyst
MRNA
Sell
46,441$65.60−$3.0M
Apr 23
RYTM
Sell
17,448$27.71−$483.5K
Apr 23
ALNY
Sell
4,128$117.65−$485.7K
Apr 23
BMY
Sell
241,967$111.15−$26.9M
Apr 23
BCRX
Option ex.
4,804$21.18$101.8K
Apr 23
ALNY
Buy
3,509$153.68+$539.3K
Apr 22
KOD
Buy
9,997$14.67+$146.6K
Apr 22
MDGL
Buy
26,465$41.46+$1.1M
Apr 22
VERV
Sell
497,016$15.83−$7.9M
Apr 22
ARDX
Sell
2,476$19.64−$48.6K
Apr 22
AKRO
Option ex.
5,062$19.81$100.3K
Apr 22
KOD
Option ex.
7,308$11.62$84.9K
Apr 21
BEAM
Award
2,437$22.91$55.8K
Apr 21
RXRX
Option ex.
2,774$15.33$42.5K
Apr 21
RYTM
Sell
11,451$34.75−$397.9K
Apr 20
INCY
Award
7,658$96.99$742.8K
Apr 20
BEAM
Sell
44,900$21.22−$952.6K
Apr 20
ARDX
Sell
23,359$19.52−$456.1K
Apr 20
IONS
Sell
6,265$40.34−$252.7K
Apr 19
RCKT
Sell
11,458$13.55−$155.2K
Apr 19
SRPT
Sell
76,019$20.85−$1.6M
Apr 18
34d to catalyst
RYTM
Buy
16,715$26.37+$440.8K
Apr 18
ALNY
Sell
456,341$131.49−$60.0M
Apr 18
EDIT
Award
4,918$14.92$73.4K
Apr 18
IMVT
Option ex.
7,417$37.23$276.1K
Apr 17
REGN
Sell
13,557$116.74−$1.6M
Apr 16
BEAM
Sell
24,195$22.20−$537.1K
Apr 16
BPMC
Option ex.
13,067$46.03$601.5K
Apr 15
CRBU
Award
2,228$11.12$24.8K
Apr 15
BIIB
Sell
9,208$104.01−$957.7K
Apr 14
IMVT
Option ex.
2,575$46.37$119.4K
Apr 14
VKTX
Option ex.
5,443$28.47$155.0K
Apr 13
RYTM
Buy
13,254$26.19+$347.2K
Apr 13
EDIT
Sell
83,405$13.34−$1.1M
Apr 13
29d to catalyst
BIIB
Buy
6,950$107.40+$746.4K
Apr 11
BIIB
Sell
82,379$90.42−$7.4M
Apr 11
VERV
Sell
18,491$17.22−$318.4K
Apr 11
SRPT
Buy
3,236$28.14+$91.1K
Apr 10
42d to catalyst
CRBU
Sell
30,879$15.42−$476.1K
Apr 10
24d to catalyst
RXRX
Sell
8,736$16.64−$145.4K
Apr 10
ARWR
Sell
3,155$25.13−$79.3K
Apr 9
36d to catalyst
CRSP
Option ex.
3,987$37.45$149.3K
Apr 8
CRBU
Sell
15,230$11.24−$171.3K
Apr 8
26d to catalyst
RYTM
Option ex.
13,146$32.57$428.1K
Apr 7
REGN
Buy
9,712$141.17+$1.4M
Apr 7
IMVT
Option ex.
12,616$48.16$607.6K
Apr 7
SRPT
Award
838$27.70$23.2K
Apr 6
BMRN
Sell
13,854$57.40−$795.2K
Apr 5
REGN
Sell
15,020$107.89−$1.6M
Apr 5
BCRX
Buy
18,415$23.87+$439.6K
Apr 5
57d to catalyst
FOLD
Sell
24,679$25.71−$634.4K
Apr 5
EDIT
Option ex.
7,263$15.38$111.7K
Apr 3
VERV
Sell
23,004$16.13−$371.1K
Apr 3
REGN
Option ex.
23,722$134.36$3.2M
Apr 2
INCY
Sell
24,095$85.67−$2.1M
Apr 2
RCKT
Sell
15,131$16.90−$255.7K
Apr 2
RYTM
Sell
73,182$25.58−$1.9M
Apr 1
BCRX
Award
8,415$22.39$188.5K
Mar 31
RYTM
Award
997$33.77$33.7K
Mar 30
ALNY
Sell
56,884$147.46−$8.4M
Mar 30
ALNY
Sell
583,406$148.04−$86.4M
Mar 30
BMRN
Sell
81,444$61.97−$5.0M
Mar 30
BMY
Sell
10,294$133.70−$1.4M
Mar 30
BEAM
Sell
14,395$24.04−$346.1K
Mar 30
VERV
Buy
5,358$12.24+$65.6K
Mar 28
FOLD
Sell
18,785$27.19−$510.8K
Mar 28
SRPT
Sell
49,322$22.65−$1.1M
Mar 27
56d to catalyst
IONS
Option ex.
8,247$34.34$283.2K
Mar 27
EDIT
Sell
41,170$16.48−$678.4K
Mar 27
46d to catalyst
BMY
Buy
25,998$115.92+$3.0M
Mar 26
ARDX
Sell
26,032$18.09−$471.0K
Mar 26
source · sec edgar form 4 · ingested in minutes

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar